Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Different functional states of topoisomerase II can be discriminated by orthovanadate sensitivity in multi-drug resistant human leukemic cells

Fritz Boege*, Frank Gieseler, Harald Biersack, Peter Meyer

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

We have studied the functional properties of topoisomerase II (Topo II) in a subclone of the HL-60 cell line, which is highly resistant to cytotoxic Topo II inhibitors, but does not express p-glycoprotein. The cells contain the two forms of human topo II with Mr 170 and 180 kDa in equal proportions. Two different states of both forms of the enzymes can be separated by anion-exchange chromatography and functionally discriminated on the basis of orthovanadate sensitivity. The EC50 of orthovanadate was 0.2 μM for the early eluting and 30 μM for the late eluting Topo II.

OriginalspracheEnglisch
ZeitschriftLeukemia and Lymphoma
Jahrgang9
Ausgabenummer4-5
Seiten (von - bis)381-383
Seitenumfang3
ISSN1042-8194
DOIs
PublikationsstatusVeröffentlicht - 1993

Fördermittel

Acknowledgemenrs This work was in part supported by the Wilhelm-Sander Stiftung, grant 90.038.1. and the Deutsche Forschungsgemeinschaft, SFB 172, C9. The authors are much indebted to Prof. L. F. Liu for the gift of rabbit anti human toDoisomerase I1 antiserum. Excellent technical assistance bv M'ichaela Miiller and Michael Clark.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Different functional states of topoisomerase II can be discriminated by orthovanadate sensitivity in multi-drug resistant human leukemic cells“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren